1 big new Green Flag for CRISPR Therapeutics' Stock
CRISPR Therapeutics (NASDAQ: CRSP) isn't a stock that's wanting for reasons to invest. Between the solid launch of its first commercialized therapy and a …
Read MoreCRISPR Therapeutics (NASDAQ: CRSP) isn't a stock that's wanting for reasons to invest. Between the solid launch of its first commercialized therapy and a …
Read MoreShares of electric vehicle (EV) charging company EVgo (NASDAQ: EVGO) fell as much as 30.4% in trading this week, according to data provided by S&P Global …
Read MoreRigetti (NASDAQ: RGTI) stock investors got great news that could have long-term implications for shareholders. Start Your Mornings Smarter! Wake up with …
Read MoreInvestors rarely find a business with these characteristics trading at this cheap valuation. Start Your Mornings Smarter! Wake up with Breakfast news in your …
Read MoreExchange-traded funds (ETFs) have become a popular investing instrument over the last few years. They provide easy and instant access to diversified holdings, …
Read MoreIn September, Riot Platforms (NASDAQ: RIOT) stock dropped down to almost $6 per share, falling to its lowest price in nearly two years. In the three short …
Read MoreFor alt-milk products specialist Oatly Group (NASDAQ: OTLY), the weekend likely can't come fast enough. The company's stock was having a rough time on the …
Read MoreInvestor sentiment on once-hot energy drink maker Celsius (NASDAQ: CELH) was cooling significantly over the past few days. Slowing growth, due in no small part …
Read MoreCybersecurity was a big news topic in 2024, and largely for the wrong reasons. While there continues to be a number of high-profile security breaches, the …
Read MoreSummit Therapeutics (NASDAQ: SMMT) has risen in prominence in the past two years thanks to a promising pipeline candidate, ivonescimab, a potential cancer …
Read More